These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1605236)

  • 61. Pure psychiatric presentation of Fragile X-associated tremor/ataxia syndrome.
    Reiner P; Taifas I; Massiou H; Jouvent E
    Eur J Neurol; 2013 Sep; 20(9):e113-4. PubMed ID: 23889896
    [No Abstract]   [Full Text] [Related]  

  • 62. Neuropsychological profiles of three sisters homozygous for the fragile X premutation.
    Mazzocco MM; Holden JJ
    Am J Med Genet; 1996 Aug; 64(2):323-8. PubMed ID: 8844074
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Carrier diagnosis of the fragile X syndrome--a challenge in antenatal clinics.
    Ryynänen M; Kirkinen P; Mannermaa A; Saarikoski S
    Am J Obstet Gynecol; 1995 Apr; 172(4 Pt 1):1236-9. PubMed ID: 7726262
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The fragile X syndrome: isolation of the FMR-1 gene and characterization of the fragile X mutation.
    Oostra BA; Verkerk AJ
    Chromosoma; 1992 Apr; 101(7):381-7. PubMed ID: 1618021
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Molecular pathology of the fragile X syndrome.
    Tsongalis GJ; Silverman LM
    Arch Pathol Lab Med; 1993 Nov; 117(11):1121-5. PubMed ID: 8239933
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Molecular analysis of the (CGG)n expansion in the FMR-1 gene in 59 Spanish fragile X syndrome families.
    Milà M; Kruyer H; Glover G; Sánchez A; Carbonell P; Castellví-Bell S; Volpini V; Rossell J; Gabarrón J; López I
    Hum Genet; 1994 Oct; 94(4):395-400. PubMed ID: 7927336
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Delineation of the working memory profile in female FMR1 premutation carriers: the effect of cognitive load on ocular motor responses.
    Shelton AL; Cornish KM; Godler DE; Clough M; Kraan C; Bui M; Fielding J
    Behav Brain Res; 2015 Apr; 282():194-200. PubMed ID: 25591477
    [TBL] [Abstract][Full Text] [Related]  

  • 68. DNA analysis of the fragile X syndrome in an at risk pediatric population in croatia: simple clinical preselection criteria can considerably improve the cost-effectiveness of fragile X screening studies.
    Hećimović S; Barisić I; Pavelić K
    Hum Hered; 1998; 48(5):256-65. PubMed ID: 9748695
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Differential impact of the FMR1 gene on visual processing in fragile X syndrome.
    Kogan CS; Boutet I; Cornish K; Zangenehpour S; Mullen KT; Holden JJ; Der Kaloustian VM; Andermann E; Chaudhuri A
    Brain; 2004 Mar; 127(Pt 3):591-601. PubMed ID: 14736752
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Neuropsychiatric symptoms of fragile X syndrome: pathophysiology and pharmacotherapy.
    Tsiouris JA; Brown WT
    CNS Drugs; 2004; 18(11):687-703. PubMed ID: 15330685
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Early behavior signs of psychiatric phenotypes in fragile X syndrome.
    Kau AS; Reider EE; Payne L; Meyer WA; Freund L
    Am J Ment Retard; 2000 Jul; 105(4):286-99. PubMed ID: 10934570
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Fragile X syndrome.
    Welch JL; Williams JK
    Neonatal Netw; 1999 Sep; 18(6):15-22. PubMed ID: 10690095
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Molecular screening of FRAXA and FRAXE in Indian patients with unexplained mental retardation.
    Pandey UB; Phadke S; Mittal B
    Genet Test; 2002; 6(4):335-9. PubMed ID: 12537661
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Prenatal carrier testing for fragile X: counseling issues and challenges.
    Musci TJ; Moyer K
    Obstet Gynecol Clin North Am; 2010 Mar; 37(1):61-70, Table of Contents. PubMed ID: 20494258
    [TBL] [Abstract][Full Text] [Related]  

  • 75. FMR1 gene deletion/reversion: a pitfall of fragile X carrier testing.
    Gasteiger M; Grasbon-Frodl E; Neitzel B; Kooy F; Holinski-Feder E
    Genet Test; 2003; 7(4):303-8. PubMed ID: 15000806
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Clinicians' experiences with the fragile X clinical and research consortium.
    Liu JA; Hagerman RJ; Miller RM; Craft LT; Finucane B; Tartaglia N; Berry-Kravis EM; Sherman SL; Kidd SA; Cohen J
    Am J Med Genet A; 2016 Dec; 170(12):3138-3143. PubMed ID: 27604509
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Living with Fragile X syndrome.
    Arch Dis Child; 2021 Feb; 106(2):204. PubMed ID: 31101619
    [No Abstract]   [Full Text] [Related]  

  • 78. Brief screening questionnaire for determining affected state in fragile X syndrome: a consensus recommendation.
    Reiss AL; Cianchetti C; Cohen IL; DeVries B; Hagerman R; Hinton V; Froster U; Lachiewicz A; Mazzocco M; Sobesky W
    Am J Med Genet; 1992 Apr 15-May 1; 43(1-2):61-4. PubMed ID: 1605236
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Advances in research on the fragile X syndrome.
    Mazzocco MM
    Ment Retard Dev Disabil Res Rev; 2000; 6(2):96-106. PubMed ID: 10899802
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The emerging fragile X premutation phenotype: evidence from the domain of social cognition.
    Cornish K; Kogan C; Turk J; Manly T; James N; Mills A; Dalton A
    Brain Cogn; 2005 Feb; 57(1):53-60. PubMed ID: 15629215
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.